Literature DB >> 3098302

The inflammatory and tumor-promoting sesquiterpene lactone, thapsigargin, activates platelets by selective mobilization of calcium as shown by protein phosphorylations.

O Thastrup, H Linnebjerg, P J Bjerrum, J B Knudsen, S B Christensen.   

Abstract

We have studied the activation of human blood platelets by the inflammatory and tumor-promoting sesquiterpene lactone, thapsigargin. The effect of thapsigargin was compared with other common agonists (calcium ionophore A23187, phorbol ester TPA and thrombin). Platelet aggregation, serotonin release, raised cytoplasmic free calcium level and phosphorylation of platelet proteins was examined in platelet-rich plasma and washed platelet suspension. In contrast to A23187 and thrombin, the platelet activation induced by thapsigargin developed slowly, with maximal response obtained after 2-3 min. Both the thapsigargin- and the A23187-induced serotonin releases were synergistically increased by TPA. Studies of the phosphorylation of platelet proteins revealed that thapsigargin and A23187 equally well induced a selective phosphorylation of two proteins with apparent molecular masses of 20 kDa and 47 kDa. These proteins, which are substrates of myosin light-chain kinase and protein kinase C respectively, are known to be involved in platelet activation. The thapsigargin-induced platelet aggregation and serotonin release was completely inhibited by class I (nimodipine), class II (verapamil) and class III (diltiazem) calcium-channel blockers. The inhibitory activity of nimodipine was abolished by the corresponding 1,4-dihydropyridine calcium-channel agonist, BAY K 8644. These results shows that the thapsigargin-induced platelet activation is mediated by an increase in the cytoplasmic free calcium level, presumably obtained by stimulation of the passive calcium transport through specific channels. These thapsigargin-sensitive channels should predominantly be located in the membranes of intracellular calcium stores rather than in the plasma membrane, because removal of extracellular calcium by EGTA had only an insignificant effect on the thapsigargin-induced rise in cytoplasmic free calcium level.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3098302     DOI: 10.1016/0167-4889(87)90066-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  24 in total

1.  A rise in the intracellular Ca2+ concentration of isolated rat supraoptic cells in response to oxytocin.

Authors:  R C Lambert; G Dayanithi; F C Moos; P Richard
Journal:  J Physiol       Date:  1994-07-15       Impact factor: 5.182

Review 2.  Role of Ca2(+)-ATPases in regulation of cellular Ca2+ signalling, as studied with the selective microsomal Ca2(+)-ATPase inhibitor, thapsigargin.

Authors:  O Thastrup
Journal:  Agents Actions       Date:  1990-01

3.  Bombesin-induced gastrin release from canine G cells is stimulated by Ca2+ but not by protein kinase C, and is enhanced by disruption of rho/cytoskeletal pathways.

Authors:  R Seensalu; D Avedian; R Barbuti; M Song; L Slice; J H Walsh
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

4.  Thapsigargin, a novel molecular probe for studying intracellular calcium release and storage.

Authors:  O Thastrup; A P Dawson; O Scharff; B Foder; P J Cullen; B K Drøbak; P J Bjerrum; S B Christensen; M R Hanley
Journal:  Agents Actions       Date:  1989-04

5.  Thapsigargin, a novel molecular probe for studying intracellular calcium release and storage. 1989.

Authors:  O Thastrup; A P Dawson; O Scharff; B Foder; P J Cullen; B K Drøbak; P J Bjerrum; S B Christensen; M R Hanley
Journal:  Agents Actions       Date:  1994-12

Review 6.  Specific inhibitors of intracellular Ca2+ transport ATPases.

Authors:  G Inesi; Y Sagara
Journal:  J Membr Biol       Date:  1994-07       Impact factor: 1.843

7.  Internal Ca2+ mobilization is altered in fibroblasts from patients with Alzheimer disease.

Authors:  E Ito; K Oka; R Etcheberrigaray; T J Nelson; D L McPhie; B Tofel-Grehl; G E Gibson; D L Alkon
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

8.  Ca2+ release from platelet intracellular stores by thapsigargin and 2,5-di-(t-butyl)-1,4-benzohydroquinone: relationship to Ca2+ pools and relevance in platelet activation.

Authors:  K S Authi; S Bokkala; Y Patel; V V Kakkar; F Munkonge
Journal:  Biochem J       Date:  1993-08-15       Impact factor: 3.857

9.  Thapsigargin-evoked changes in human platelet Ca2+, Na+, pH and membrane potential.

Authors:  M Kimura; N Lasker; A Aviv
Journal:  J Physiol       Date:  1993-05       Impact factor: 5.182

10.  A novel tumour promoter, thapsigargin, transiently increases cytoplasmic free Ca2+ without generation of inositol phosphates in NG115-401L neuronal cells.

Authors:  T R Jackson; S I Patterson; O Thastrup; M R Hanley
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.